1)日本食道学会(編).食道癌診療ガイドライン2017年版.金原出版,2017
2)武藤学(研究代表者).総括報告書 JCOG0508:「粘膜下層浸潤臨床病期I期(T1N0M0)食道癌に対する内視鏡的粘膜切除術(EMR)と化学放射線併用治療の有効性に関する非ランダム化検証的試験」.http://www.jcog.jp/document/s_0508.pdf(2020年8月12日アクセス)
3)真能正幸,上堂文也,石黒信吾,他.食道m3・sm1癌の臨床病理.胃と腸 37:11-17, 2002
4)根本哲生,伊東干城,堀口慎一郎,他.治療成績からみた食道m3・sm癌の治療方針—外科手術例におけるリンパ節転移:病理の立場から.胃と腸 41:1416-1427, 2006
5)藤田昌宏,佐藤利宏,細川正夫,他.治療成績からみた食道m3・sm癌の治療方針—外科手術例におけるリンパ節転移と病理像.胃と腸 41:1407-1415, 2006
6)江頭秀人,柳澤昭夫,加藤洋.m3食道癌におけるリンパ節転移予測因子—滴状浸潤(droplet infiltration)の有用性.Gastroenterol Endosc 46:2086-2094, 2004
7)Egashira H, Yanagisawa A, Kato Y. Predictive factors for lymph node metastasis in esophageal squamous cell carcinomas contacting or penetrating the muscularis mucosae:the utility of droplet infiltration. Esophagus 3:47-52, 2006
8)八尾隆史,野村亮介,梶山美明.悪性度の高い食道表在癌—臨床病理学的特徴.胃と腸 48:1245-1252, 2013
9)Nakagawa Y, Ohira M, Kubo N, et al. Tumor budding and E-cadherin Expression are useful predictors of nodal involvement in T1 esophageal squamous cell carcinoma. Anticancer Res 33:5023-5029, 2013
10)Teramoto H, Koike M, Tanaka C, et al. Tumor budding as a useful prognostic marker in T1-stage squamous cell carcinoma of the esophagus. J Surg Oncol 108:42-46, 2013
11)Berg KB, Schaeffer DF. Tumor budding as a standardized parameter in gastrointestinal carcinomas:more than just the colon. Mod Pathol 31:862-872, 2018
12)Fuchinoue K, Nemoto T, Shimada H, et al. Immunohistochemical analysis of tumor budding as predictor of lymph node metastasis from superficial esophageal squamous cell carcinoma. Esophagus 17:168-174, 2020
13)Lugli A, Kirsch R, Ajioka Y, et al. Recommendations for reporting tumor budding in colorectal cancer based on the International Tumor Budding Consensus Conference(ITBCC)2016. Mod Pathol 30:1299-1311, 2017
14)Takamatsu M, Kawachi H, Yamamoto N, et al. Immunohistocchemical evaluation of tumor budding for stratifying T1 colorectal cancer:optimal cut-off value and a novel computer-assisted semiautomatic method. Mod Pathol 32:675-683, 2019
15)Hanahan D, Weinberg RA. Hallmarks of cancer:the next generation. Cell 144:646-674, 2011
16)Sasahara T, Kirita T. Hallmarkes of cancer-related newly prognostic factors of oral squamous cell carcinoma. Int J Mol Sci 19:2413, 2018
17)Rong L, Wang B, Guo L, et al. HER2 expression and relevant clinicopathological features in esophageal squamous cell carcinoma in a Chinese population. Diagn Pathol 15:27, 2020
18)Wang L, Yu X, Li J, et al. Prognostic significance of p53 expression in patients with esophageal cancer:a meta-analysis. BMC Cancer 16:373, 2016
19)Metges J, François E, Shah M, et al. The phase 3 KEYNOTE-181 study:pembrolizumab versus chemotherapy as second-line therapy for advanced esophageal cancer. Ann Oncol 30(Suppl 4):IV130, 2019
20)Lin Y, Shen LY, Fu H, et al. P21, COX-2, and E-cadherin are potential prognostic factors for esophageal squamous cell carcinoma. Dis Esophagus 30:1-10, 2017
21)Zhang DH, Chen JY, Hong CQ, et al. High-risk human papillomavirus infection associated with telomere elongation in patients with esophageal squamous cell carcinoma with poor prognosis. Cancer 120:2673-2683, 2014
22)Rao X, Huang D, Sui X, et al. Overexpression of WRAP53 is associated with development and progression of esophageal squamous cell carcinoma. PLoS One 9:e91670, 2014
23)Ma G, Zhang J, Jiang H, et al. Microvessel density as a prognostic factor in esophageal squamous cell cancer patients:A meta-analysis. Medicine(Baltimore) 96:e7600, 2017
24)Ilson DH, Hillegersberg R. Management of patients with adenocarcinoma or squamous cancer of the esophagus. Gastroenterology 154:437-451, 2018
25)Sawada G, Niida A, Uchi R, et al. Genomic landscape of esophageal squamous cell carcinoma in a Japanese population. Gastroenterology 150:1171-1182, 2016
26)Nemoto T, Kitagawa M, Hasegawa M, et al. Expression of IAP family proteins in esophageal cancer. Exp Mol Pathol 76:253-259, 2004
27)de Andrade Barreto E, de Souza Santos PT, Bergmann A, et al. Alterations in glucose metabolism proteins responsible for the Warburg effect in esophageal squamous cell carcinoma. Exp Mol Pathol 101:66-73, 2016